Clinical Trials Browser

Phase 2/3 × Stage II Prostate Adenocarcinoma × Magnetic Resonance Spectroscopy × Clear all

NCT02678351 2022-03-04

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Phase 2/3 Completed

74 enrolled 9 charts

Stage II Prostate Adenocarcinoma